Roughly half of all Americans aged 14 to 49 have HSV-1, the virus most commonly associated with oral herpes and cold sores. The most recent national survey data, from 2015–2016, puts the figure at 48.1%. Globally, the rate is higher, with the majority of people under 50 carrying the virus. What makes HSV-1 unusual is that most people who have it don’t know, because the infection rarely causes noticeable symptoms.
HSV-1 Prevalence in the United States
The CDC’s national health survey found that 48.1% of adolescents and adults aged 14 to 49 tested positive for HSV-1 antibodies in 2015–2016. That’s down significantly from 59.4% in 1999–2000, a drop of more than 11 percentage points over roughly 15 years. The decline held across all racial and ethnic groups surveyed: prevalence among non-Hispanic white Americans fell from 52.4% to 36.9%, among non-Hispanic Black Americans from 68.4% to 58.8%, and among Mexican-American individuals from 82.0% to 71.7%.
Women carry the virus at slightly higher rates than men. In that same survey period, 50.9% of females tested positive compared to 45.2% of males. Keep in mind that these numbers only cover people up to age 49. Because HSV-1 is a lifelong infection and exposure accumulates over a lifetime, the true percentage among older adults is almost certainly higher.
Why the Numbers Are Dropping
The steady decline in HSV-1 likely reflects changes in hygiene, living conditions, and possibly less casual physical contact among children and teens. In earlier decades, most people picked up HSV-1 in childhood through ordinary contact like shared utensils or kisses from family members. Improved sanitation and smaller household sizes mean fewer children are exposed early.
This sounds like straightforwardly good news, but it creates a paradox. People who don’t encounter HSV-1 as children reach adolescence and adulthood without any immunity to the virus. When they’re eventually exposed through kissing or sexual contact, they can develop not only oral infections but genital ones as well. In countries like Canada, roughly 37% of new genital herpes cases are now caused by HSV-1 rather than HSV-2. In Europe the figure is about 34%, and in Australia around 33%. In the U.S., the proportion is lower at about 15%, but the overall trend is the same: HSV-1 is accounting for a growing share of genital herpes diagnoses, particularly among young adults.
Global Rates Are Much Higher
The U.S. figure of 48% is actually low by global standards. In many parts of Africa, Southeast Asia, and the Eastern Mediterranean, HSV-1 infection rates among adults approach 80% or higher. In these regions, most people acquire the virus during childhood, which is why rates are so much higher by adulthood. The World Health Organization estimates that the vast majority of the global population under age 50 carries HSV-1.
The pattern is consistent: countries with higher incomes and better sanitation tend to have lower childhood infection rates, which paradoxically pushes first infections into the teenage and adult years when the consequences can be different.
Most People Never Have Symptoms
The majority of people with HSV-1 never develop cold sores or any recognizable symptoms. Many carry the virus for their entire lives without knowing it. Even among those who do get cold sores, outbreaks typically become less frequent and less severe over time.
The virus does remain active at low levels even without visible sores, a process called viral shedding. Research from the University of Washington tracked shedding in people with HSV-1 infections and found the virus was detectable on about 12% of days at two months after infection. By 11 months, that had dropped to 7% of days. Among people who were still shedding relatively often at 11 months, follow-up testing two years later showed shedding on just 1.3% of days. In nearly all cases, the shedding happened without any symptoms the person could feel. This is why the virus spreads so easily: people transmit it during periods when they have no idea they’re contagious.
Why Actual Numbers May Be Higher
The 48% figure for the U.S. likely undercounts the real number of infections. Standard blood tests for HSV-1 antibodies are imperfect. A 2024 analysis of widely used commercial tests found that most had sensitivity below 85%, meaning they miss roughly one in six or more true infections. One test platform achieved 92% sensitivity but at the cost of lower accuracy in the other direction, flagging some uninfected people as positive. Specificity across the major tests was generally above 97%, so false positives are rare, but missed infections are not.
Because the virus causes no symptoms in most people and routine screening isn’t standard practice, the real prevalence is almost certainly several percentage points higher than survey data suggests. If you’ve never been tested, there’s a reasonable chance you carry HSV-1 without knowing it, especially if you’re over 30.
What These Numbers Mean in Practical Terms
HSV-1 is one of the most common viral infections in humans. At current U.S. rates, roughly one in two people you interact with carries the virus. Globally, the proportion is even higher. The infection is lifelong but, for the overwhelming majority of people, causes either no symptoms or occasional cold sores that become less frequent with time.
The main practical concern is transmission during asymptomatic periods. If you get cold sores, you’re most contagious during an active outbreak, but low-level shedding between outbreaks means the virus can spread even when your skin looks completely normal. This is especially relevant for avoiding transmission to newborns, who can develop serious complications from HSV-1, and for sexual partners who may not have been previously exposed.